STAT Plus: Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’
MIKE REDDY/STAT
In this edition: Will #JPM21 be a thing? Also, some straight talk from Alexis Borisy, Daphne Zohar and Abbie Celniker, and another biotech investor survey.
.png)
No hay comentarios:
Publicar un comentario